4.Other Non-Current Assets
Other non-current assets consisted of the following (in thousands):
March 31, 2026
December 31, 2025
Clinical trial deposits
$
14,535
12,882
Deferred offering costs
439
709
Other
86
218
Total other assets
15,060
13,809
The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.
No definition available.